autoimmune epilepsychildrendietary treatmentepilepsyepilepsy surgeryneuroinflammationneurostimulationpersonalized medicineThe epilepsies are the most common chronic neurological disorders in children. Considerable steps towards a better understanding of different aspects of the once considered 'sacred disease' have been...
Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 75, 279–286 (2018). Article PubMed Google Scholar Löscher, W. et al. Drug resistance in epilepsy: clinical impact, potential ...
The promise of gene therapy for the treatment of epilepsy. The recent advances in refining gene therapy tools and in methods of gene delivery make this innovative approach a definite possibility for therapeutic ... Annamaria,Vezzani - 《Expert Review of Neurotherapeutics》 被引量: 27发表: 2007年...
for Epilepsy Drugs Disease Mechanisms-Epilepsy: New Target for Epilepsy DrugsDisease Mechanisms-Epilepsy: New Target for Epilepsy Drugsdoi:10.1097/01.NT.0000544102.64679.79Dan HurleyNeurology Today
Researchers at the Francis Crick Institute, UCL and MSD have identified a potential treatment target for a genetic type of epilepsy. Ad Developmental and epileptic encephalopathies are rare types of epilepsy that start in early childhood. One of the most common types of genetic epilepsy, CDKL5 ...
Epilepsy is the most common serious chronic neurological disorder, affecting 65 million people worldwide. Antiepileptic drugs (AEDs) constitute the main treatment for epilepsy. The introduction of 14 new AEDs over the last three decades ... B. A. Alsfouk 被引量: 0发表: 2018年 Efficacy and to...
functions as aneuroprotective agent, counteracting excitotoxicity (damage from excessive excitatory neurotransmitters). Furthermore, AV-101 is under investigation as a possible treatment for other medical conditions such as epilepsy and neuropathic pain. Currently, AV-101 is in Phase II of clinical ...
Credit: American Chemical Society New treatments for epilepsy are sorely needed because current medications don't work for many people with the disease. To find new leads, researchers have now turned to the sea—a source of unique natural products that have been largely untapped for prospective dr...
Therefore, between 1996 and 2018, among 14 new antiepileptic drugs (AEDs) approved for the treatment of epilepsy as many as seven drugs were chiral and introduced in the market in the single銆唍antiomer (or diastereoisomer) format. This article provides an overview of the impact of chirality ...
This longitudinal cohort study assessed treatment outcomes in patients with newly diagnosed epilepsy and calculated the probability of achieving seizure